Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Change in Accured Expenses (2021 - 2025)

ARS Pharmaceuticals (SPRY) has disclosed Change in Accured Expenses for 5 consecutive years, with -$9.1 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 218.27% to -$9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Dec 2025, up 15.04% year-over-year, with the annual reading at $18.9 million for FY2025, 15.04% up from the prior year.
  • Change in Accured Expenses hit -$9.1 million in Q4 2025 for ARS Pharmaceuticals, down from $11.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $12.8 million in Q2 2025 to a low of -$11.4 million in Q4 2022.
  • Historically, Change in Accured Expenses has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: soared 1268.75% in 2024 and later tumbled 218.27% in 2025.
  • Year by year, Change in Accured Expenses stood at -$5.4 million in 2021, then crashed by 109.67% to -$11.4 million in 2022, then grew by 22.25% to -$8.9 million in 2023, then soared by 186.3% to $7.7 million in 2024, then crashed by 218.27% to -$9.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for SPRY at -$9.1 million in Q4 2025, $11.0 million in Q3 2025, and $12.8 million in Q2 2025.